Baxter Called Out for Numerous Issues at Colombian Plant

Drug Industry Daily
A A
The FDA hit Baxter with a Form 483 after multiple problems were discovered at its Valle del Cauca, Colombia facility during a June 4-8 inspection.

To View This Article:

Login

Subscribe To Drug Industry Daily